chronic leukemia (Cancer)

Search with Google Search with Bing
Information
Disease name
chronic leukemia
Disease ID
DOID:1036
Description
"A leukemia that develops slowly." [url:http\://www.nlm.nih.gov/medlineplus/leukemiaadultchronic.html]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00899223 Active, not recruiting Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes May 1996
NCT00273936 Completed Phase 1 Trial of AVN-944 in Patients With Advanced Hematologic Malignancies January 2006
NCT01336712 Completed Phase 2 Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases April 2011 July 2015
NCT01362985 Completed Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor July 2009 July 2014
NCT00230282 Completed Phase 2 Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia July 2004 October 2011
NCT02842333 Completed N/A Study of Predictive Immunological Parameters of Molecular Complete Remission in Patients With Chronic Myelogenous Leukemia in Chronic Phase and Treated With Tyrosine Kinase Inhibitor May 2016 October 6, 2020
NCT02169791 Completed Phase 2 Nonmyeloablative Haploidentical Transplant Followed by MLN9708 July 15, 2014 July 28, 2020
NCT02451592 Completed Fungemia in Hematologic Malignancies January 2011 January 2016
NCT06063603 Recruiting N/A Evaluation of a Pain Management Intervention Preparatory to a Future Pragmatic Trial, ASCENT Study May 25, 2023 May 25, 2026
NCT03016806 Recruiting Phase 1 Umbilical Cord Blood Transplantation From Unrelated Donors June 2015 June 2026
NCT04965649 Recruiting Is There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance Mutations in Phi+ Hematological Malignancies. January 1, 2021 January 1, 2025
NCT05645510 Recruiting LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study November 24, 2022 May 30, 2025
NCT03588936 Terminated Phase 1 Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant September 14, 2018 July 15, 2020
NCT01624701 Terminated Phase 1/Phase 2 Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells March 2012 July 2016
NCT01598025 Terminated N/A Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor May 2, 2012 October 16, 2017
NCT01472055 Unknown status Phase 2 Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation October 2011 September 2014
NCT01800643 Unknown status Phase 2/Phase 3 Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation March 2010 December 2014
Disase is a (Disease Ontology)
DOID:1240
Cross Reference ID (Disease Ontology)
NCI:C3483
Disase Synonym (Disease Ontology)
adult chronic leukemia
Disase Synonym (Disease Ontology)
CLL
Disase Synonym (Disease Ontology)
CML
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0005558